ImmuCell Stock (NASDAQ: ICCC) stock price, news, charts, stock research, profile.
You can purchase shares of ImmuCell (NASDAQ:ICCC) through any online brokerage.
Other companies in ImmuCell’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for ImmuCell to provide a consensus price target.
The stock price for ImmuCell (NASDAQ: ICCC) is $4.19 last updated December 20, 2024 at 4:34 PM EST.
There are no upcoming dividends for ImmuCell.
ImmuCell’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for ImmuCell.
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.